Here is how Agilon Health (AGL) and Caribou Biosciences, Inc. (CRBU) have performed compared to their sector so far this year.
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Agilon Health (AGL) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Agilon Health is one of 891 individual stocks in the Medical sector. Collectively, these companies sit at #6 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Agilon Health is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for AGL's full-year earnings has moved 40.2% higher within the past quarter. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
Our latest available data shows that AGL has returned about 64.4% since the start of the calendar year. Meanwhile, stocks in the Medical group have lost about 5.5% on average. This shows that Agilon Health is outperforming its peers so far this year.
Another stock in the Medical sector, Caribou Biosciences, Inc. (CRBU), has outperformed the sector so far this year. The stock's year-to-date return is 44%.
For Caribou Biosciences, Inc., the consensus EPS estimate for the current year has increased 9.9% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Agilon Health belongs to the Medical Services industry, a group that includes 62 individual companies and currently sits at #87 in the Zacks Industry Rank. This group has lost an average of 9.5% so far this year, so AGL is performing better in this area.
Caribou Biosciences, Inc., however, belongs to the Medical - Biomedical and Genetics industry. Currently, this 436-stock industry is ranked #92. The industry has moved +2.5% so far this year.
Agilon Health and Caribou Biosciences, Inc. could continue their solid performance, so investors interested in Medical stocks should continue to pay close attention to these stocks.
The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.
See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Join 500,000+ readers who start their day with Quartz.
By subscribing, you agree to our Terms of Service and Privacy Policy.
